1. Home
  2. RVSB vs GLSI Comparison

RVSB vs GLSI Comparison

Compare RVSB & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVSB
  • GLSI
  • Stock Information
  • Founded
  • RVSB 1923
  • GLSI 2006
  • Country
  • RVSB United States
  • GLSI United States
  • Employees
  • RVSB N/A
  • GLSI N/A
  • Industry
  • RVSB Savings Institutions
  • GLSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVSB Finance
  • GLSI Health Care
  • Exchange
  • RVSB Nasdaq
  • GLSI Nasdaq
  • Market Cap
  • RVSB 119.6M
  • GLSI 134.6M
  • IPO Year
  • RVSB 1993
  • GLSI 2020
  • Fundamental
  • Price
  • RVSB $5.43
  • GLSI $11.68
  • Analyst Decision
  • RVSB Buy
  • GLSI Strong Buy
  • Analyst Count
  • RVSB 1
  • GLSI 1
  • Target Price
  • RVSB $7.00
  • GLSI $39.00
  • AVG Volume (30 Days)
  • RVSB 262.3K
  • GLSI 70.6K
  • Earning Date
  • RVSB 08-01-2025
  • GLSI 08-13-2025
  • Dividend Yield
  • RVSB 1.47%
  • GLSI N/A
  • EPS Growth
  • RVSB 27.97
  • GLSI N/A
  • EPS
  • RVSB 0.23
  • GLSI N/A
  • Revenue
  • RVSB $50,239,000.00
  • GLSI N/A
  • Revenue This Year
  • RVSB $12.68
  • GLSI N/A
  • Revenue Next Year
  • RVSB $11.53
  • GLSI N/A
  • P/E Ratio
  • RVSB $23.70
  • GLSI N/A
  • Revenue Growth
  • RVSB 3.95
  • GLSI N/A
  • 52 Week Low
  • RVSB $4.20
  • GLSI $8.06
  • 52 Week High
  • RVSB $6.59
  • GLSI $17.00
  • Technical
  • Relative Strength Index (RSI)
  • RVSB 43.91
  • GLSI 72.18
  • Support Level
  • RVSB $5.33
  • GLSI $10.00
  • Resistance Level
  • RVSB $5.53
  • GLSI $12.54
  • Average True Range (ATR)
  • RVSB 0.12
  • GLSI 0.69
  • MACD
  • RVSB -0.01
  • GLSI 0.26
  • Stochastic Oscillator
  • RVSB 32.69
  • GLSI 92.16

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.

Share on Social Networks: